| Year |
Citation |
Score |
| 2016 |
Ezelle HJ, Malathi K, Hassel BA. The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response. International Journal of Molecular Sciences. 17. PMID 26760998 DOI: 10.3390/Ijms17010074 |
0.491 |
|
| 2014 |
Malathi K, Siddiqui MA, Dayal S, Naji M, Ezelle HJ, Zeng C, Zhou A, Hassel BA. RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry. Mbio. 5: e02012. PMID 25352621 DOI: 10.1128/Mbio.02012-14 |
0.463 |
|
| 2014 |
Brennan-Laun SE, Li XL, Ezelle HJ, Venkataraman T, Blackshear PJ, Wilson GM, Hassel BA. RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response. The Journal of Biological Chemistry. 289: 33629-43. PMID 25301952 DOI: 10.1074/Jbc.M114.589556 |
0.453 |
|
| 2014 |
Brennan-Laun SE, Ezelle HJ, Li XL, Hassel BA. RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 34: 275-88. PMID 24697205 DOI: 10.1089/Jir.2013.0147 |
0.454 |
|
| 2013 |
Long TM, Chakrabarti A, Ezelle HJ, Brennan-Laun SE, Raufman JP, Polyakova I, Silverman RH, Hassel BA. RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer. Inflammatory Bowel Diseases. 19: 1295-305. PMID 23567782 DOI: 10.1097/Mib.0B013E318281F2Fd |
0.408 |
|
| 2013 |
Lee TY, Ezelle HJ, Venkataraman T, Lapidus RG, Scheibner KA, Hassel BA. Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 33: 34-42. PMID 23113544 DOI: 10.1089/Jir.2012.0062 |
0.367 |
|
| 2013 |
Brennan-Laun SE, Li X, Ezelle HJ, Wilson GM, Hassel BA. Abstract 3197: RNase-L modulates transcriptional and post-transcriptional responses to mitogenic stimuli through serum response factor and tristetraprolin. Cancer Research. 73: 3197-3197. DOI: 10.1158/1538-7445.Am2013-3197 |
0.451 |
|
| 2013 |
Long TM, Chakrabarti A, Ezelle H, Brennan-Laun S, Raufman J, Polyakova I, Silverman R, Hassel B. Abstract 2863: RNase-L modulates the immune response to intestinal damage and ameliorates murine colitis and colitis-associated cancer. Cancer Research. 73: 2863-2863. DOI: 10.1158/1538-7445.Am2013-2863 |
0.41 |
|
| 2012 |
Ezelle HJ, Hassel BA. Pathologic effects of RNase-L dysregulation in immunity and proliferative control. Frontiers in Bioscience (Scholar Edition). 4: 767-86. PMID 22202089 DOI: 10.2741/S298 |
0.446 |
|
| 2012 |
Hassel B, Hsi T, Ezelle H, Scheibner K. P140 MicroRNA-29 regulation of RNase-L reveals a novel function in oncogenesis Cytokine. 59: 565. DOI: 10.1016/J.Cyto.2012.06.233 |
0.369 |
|
| 2011 |
Li XL, Ezelle HJ, Hsi TY, Hassel BA. A central role for RNA in the induction and biological activities of type 1 interferons. Wiley Interdisciplinary Reviews. Rna. 2: 58-78. PMID 21956969 DOI: 10.1002/Wrna.32 |
0.406 |
|
| 2009 |
Ezelle HJ, Andersen JB, Hao I, Hassel BA. LNX is a novel protein interactor for the antiviral endoribonuclease, RNase-L Cytokine. 48: 86-87. DOI: 10.1016/J.Cyto.2009.07.313 |
0.414 |
|
| 2008 |
Li XL, Ezelle HJ, Kang TJ, Zhang L, Shirey KA, Harro J, Hasday JD, Mohapatra SK, Crasta OR, Vogel SN, Cross AS, Hassel BA. An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity. Proceedings of the National Academy of Sciences of the United States of America. 105: 20816-21. PMID 19075243 DOI: 10.1073/Pnas.0807265105 |
0.452 |
|
| 2008 |
Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology. 373: 85-97. PMID 18082865 DOI: 10.1016/J.Virol.2007.10.042 |
0.322 |
|
| 2007 |
Li XL, Andersen JB, Ezelle HJ, Wilson GM, Hassel BA. Post-transcriptional regulation of RNase-L expression is mediated by the 3'-untranslated region of its mRNA. The Journal of Biological Chemistry. 282: 7950-60. PMID 17237228 DOI: 10.1074/Jbc.M607939200 |
0.42 |
|
| 2006 |
Majid AM, Ezelle H, Shah S, Barber GN. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle. Journal of Virology. 80: 6993-7008. PMID 16809305 DOI: 10.1128/Jvi.00365-06 |
0.534 |
|
| 2005 |
Faria PA, Chakraborty P, Levay A, Barber GN, Ezelle HJ, Enninga J, Arana C, van Deursen J, Fontoura BM. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Molecular Cell. 17: 93-102. PMID 15629720 DOI: 10.1016/J.Molcel.2004.11.023 |
0.537 |
|
| 2004 |
Ferracci F, Day JB, Ezelle HJ, Plano GV. Expression of a functional secreted YopN-TyeA hybrid protein in Yersinia pestis is the result of a +1 translational frameshift event. Journal of Bacteriology. 186: 5160-6. PMID 15262954 DOI: 10.1128/Jb.186.15.5160-5166.2004 |
0.325 |
|
| 2002 |
Ezelle HJ, Markovic D, Barber GN. Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector. Journal of Virology. 76: 12325-34. PMID 12414973 DOI: 10.1128/Jvi.76.23.12325-12334.2002 |
0.541 |
|
| 2001 |
Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, Barber GN, Levy DE, Mukaida N, Gretch DR. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. Journal of Virology. 75: 6095-106. PMID 11390611 DOI: 10.1128/Jvi.75.13.6095-6106.2001 |
0.588 |
|
| 2001 |
Ezelle HJ, Balachandran S, Sicheri F, Polyak SJ, Barber GN. Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A Virology. 281: 124-137. PMID 11222103 DOI: 10.1006/Viro.2001.0815 |
0.554 |
|
| Show low-probability matches. |